Back to Search
Start Over
A comparison of two depressive symptomatology measures in residential substance abuse treatment clients.
- Source :
-
Journal of substance abuse treatment [J Subst Abuse Treat] 2009 Oct; Vol. 37 (3), pp. 318-25. Date of Electronic Publication: 2009 Apr 08. - Publication Year :
- 2009
-
Abstract
- Comorbid depression is common among substance abusers, making routine assessment of depression critical for high-quality care. We evaluated two of the most commonly used depressive symptomatology measures in a sample of clients (N = 240) in residential substance abuse treatment settings. The Beck Depression Inventory (BDI-II) has previously been used in clients receiving substance abuse treatment. The Patient Health Questionnaire (PHQ-9), originally developed for primary care settings, has not been used as frequently in substance abuse treatment settings, and it is unknown how it performs in this population. The measures were highly correlated with each other (r = .76) and demonstrated good internal consistency reliability (BDI-II = 0.91, PHQ-9 = 0.87); however, the PHQ-9 classifies more individuals as having "mild" depression symptoms relative to the BDI-II, which tends to suggest these individuals have no depression symptoms. Implications for assessing depression symptoms in individuals receiving substance abuse treatment are discussed.
- Subjects :
- Depressive Disorder complications
Diagnosis, Dual (Psychiatry)
Female
Humans
Male
Psychometrics
Residential Treatment
Severity of Illness Index
Substance Abuse Treatment Centers
Substance-Related Disorders rehabilitation
Depressive Disorder diagnosis
Psychiatric Status Rating Scales
Substance-Related Disorders complications
Subjects
Details
- Language :
- English
- ISSN :
- 1873-6483
- Volume :
- 37
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Journal of substance abuse treatment
- Publication Type :
- Academic Journal
- Accession number :
- 19359127
- Full Text :
- https://doi.org/10.1016/j.jsat.2009.03.005